|
[1]
|
Marking U, Bladh O, Havervall S, Greilert-Norin N, Gordon M, Alm JJ, et al. Mucosal IgA protects against BQ. 1 and BQ.1.1 infection. Lancet Infect Dis 2023;23(8):e272 − 3. https://doi.org/10.1016/s1473-3099(23)00421-8CrossRef
|
|
[2]
|
Liew F, Talwar S, Cross A, Willett BJ, Scott S, Logan N, et al. SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination. EBioMedicine 2023;87:104402. https://doi.org/10.1016/j.ebiom.2022.104402CrossRef
|
|
[3]
|
Marking U, Bladh O, Havervall S, Svensson J, Greilert-Norin N, Aguilera K, et al. 7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection. Lancet Infect Dis 2023;23(2):150 − 2. https://doi.org/10.1016/s1473-3099(22)00834-9CrossRef
|
|
[4]
|
World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance, 28 January 2020. Geneva (Switzerland): World Health Organization; 2020. https://iris.who.int/handle/10665/330893. |
|
[5]
|
Havervall S, Marking U, Svensson J, Greilert-Norin N, Bacchus P, Nilsson P, et al. Anti-spike mucosal IgA protection against SARS-CoV-2 omicron infection. N Engl J Med 2022;387(14):1333 − 6. https://doi.org/10.1056/NEJMc2209651CrossRef
|
|
[6]
|
Levring MB, Holm DK, Nilsson AC, Bauer JM, Jensen IS, Davidsen JR, et al. SARS-CoV-2 antibody kinetics in blood donors with a previously positive SARS-CoV-2 antibody test within a seroprevalence survey. J Med Virol 2022;94(4):1711 − 6. https://doi.org/10.1002/jmv.27486CrossRef
|
|
[7]
|
Sano K, Bhavsar D, Singh G, Floda D, Srivastava K, Gleason C, et al. SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals. Nat Commun 2022;13(1):5135. https://doi.org/10.1038/s41467-022-32389-8CrossRef
|
|
[8]
|
Cervia C, Nilsson J, Zurbuchen Y, Valaperti A, Schreiner J, Wolfensberger A, et al. Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19. J Allergy Clin Immunol 2021;147(2):545 − 57.e9. https://doi.org/10.1016/j.jaci.2020.10.040CrossRef
|
|
[9]
|
de Melo Batista dos Santos J, Soares CP, Monteiro FR, Mello R, do Amaral JB, Aguiar AS, et al. In nasal mucosal secretions, distinct IFN and IgA responses are found in severe and mild SARS-CoV-2 infection. Front Immunol 2021;12:595343. https://doi.org/10.3389/fimmu.2021.595343CrossRef
|